Génomic Vision SA organizacji FCF yield
Jaka jest wartość FCF yield organizacji Génomic Vision SA?
Wartość FCF yield organizacji Génomic Vision SA to -101.20%
Jaka jest definicja FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield firm w Health Care sektor na EURONEXT w porównaniu do Génomic Vision SA
Czym się zajmuję organizacja Génomic Vision SA?
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Firmy z fcf yield podobne do Génomic Vision SA
- Wartość FCF yield organizacji Advanced Emissions Solutions Inc to -101.74%
- Wartość FCF yield organizacji St. James Gold to -101.60%
- Wartość FCF yield organizacji Discovery Harbour Resources to -101.58%
- Wartość FCF yield organizacji Mirriad Advertising plc to -101.57%
- Wartość FCF yield organizacji Freeport Resources to -101.31%
- Wartość FCF yield organizacji Centogene N.V. Eo ,12 to -101.23%
- Wartość FCF yield organizacji Génomic Vision SA to -101.20%
- Wartość FCF yield organizacji Pesorama Inc to -101.20%
- Wartość FCF yield organizacji Chemesis International to -101.16%
- Wartość FCF yield organizacji Pathway Health Corp to -100.99%
- Wartość FCF yield organizacji Collector AB (publ) to -100.45%
- Wartość FCF yield organizacji MusclePharm to -100.34%
- Wartość FCF yield organizacji National Bank of Canada to -99.78%